Advances in Cardiovascular Pharmacotherapy. IX. Protection Against Major Adverse Cardiovascular Events by Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Obesity

Journal of Cardiothoracic and Vascular Anesthesia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles